Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours

International Journal of Experimental Pathology

Volumn 83, Issue 4, 2002, Pages 173-182

  Jang, Tae Jung ^a   Jung, Ho Guen ^a   Jung, Ki Hoon ^a   O, Min Ku ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Rat mammary tumour

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIMETHYLBENZ[A]ANTHRACENE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CANCER STAGING; CARCINOMA CELL; CARCINOMA IN SITU; CELL COUNT; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ASSAY; EPITHELIUM TUMOR; FEMALE; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MAMMARY GLAND; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STROMA; STROMA CELL; TISSUE LEVEL; TUMOR CELL; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 0036911195     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2002.00228.x     Document Type: Article

References (48)

1. Aaltomaa S., Lipponen P., Papinaho S. & Kosma V.M. (1993) Mast cells in breast cancer. Anticancer Res. 13, 785-788.
2. Coussens L.M., Raymond W.W., Bergers G. et al. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382-1397.
3. Duncan L.M., Richards L.A. & Mihm M.C. Jr (1998) Increased mast cell density in invasive melanoma. J. Cutan. Pathol. 25, 11-15.
4. Egan K.M., Stampfer M.J., Giovannucci E., Rosner B.A. & Colditz G.A. (1996) Prospective study of regular aspirin use and the risk of breast cancer. J. Nat. Cancer Inst. 88, 988-993.
5. Ermert L., Ermert M., Goppelt-Struebe M. et al. (1998) Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am. J. Respir. Cell Mol. Biol. 18, 479-488.
6. Fendl K.C. & Zimniski S.J. (1992) Role of tamoxifen in the induction of hormone-independent rat mammary tumours. Cancer Res. 52, 235-237.
7. Fukutake M., Nakatsugi S., Isoi T. et al. (1998) Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 19, 1939-1942.
8. Garay C.A. & Engstrom P.F. (1999) Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology 13, 89-98.
9. Hamid R., Singh J., Reddy B.S. & Cohen L.A. (1999) Inhibition by dietary menhaden oil of cyclooxygenase-1 and 2 in N-nitrosomethylurea-induced rat mammary tumours. Int. J. Oncol. 14, 523-528.
10. Harris R.E., Alshafie G.A., Abou-Issa H.M. & Seibert K. (2000) Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 60, 2101-2103.
11. Harris R.E., Namboodiri K.K. & Farrar W.B. (1996) Non-steroidal antiinflammatory drugs and breast cancer. Epidemiology 7, 203-205.
12. Herschman H.R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140.
13. Hull M.A., Booth J.K., Tisbury A. et al. (1999) Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br. J. Cancer 79, 1399-1405.
14. Hwang D., Scollard D., Byrne J. & Levine E. (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Nat. Cancer Inst. 90, 455-460.
15. Jacoby R.F., Seibert K., Cole C.E., Kelloff G. & Lubet R.A. (2000) The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res. 60, 5040-5044.
16. Kawamori T., Rao C.V., Seibert K. & Reddy B.S. (1998) Chemoprevention activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409-412.
17. Kutchera W., Jones D.A., Matsunami N. et al. (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Nat. Acad. Sci. USA 93, 4816-4820.
18. Liu C.H., Chang S.H., Narko K. et al. (2001) Overexpression of cyclooxygenase-2 is sufficient to induce tumourigenesis in transgenic mice. J. Biol. Chem. 276, 18563-18569.
19. Nakatsugi S., Ohta T., Kawamori T. et al. (2000) Chemoprevention by nimelsulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhlP)-induced mammary gland carcinogenesis in rats. Jap. J. Cancer Res. 91,886-892.
20. Nakatsugi S., Terada N., Yoshimura T., Horie Y. & Furukawa M. (1996) Effects of nimelsulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress induced gastric lesions in rats. Prostaglandins Leukot. Essent. Fatty Acids 55, 395-402.
21. Norrby K. & Wooley D.E. (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. Adv. Biosci. 89, 71-115.
22. Ohno R., Yoshinaga K., Fujita T. et al. (2001) Depth of invasion parallels increased cyclooxygenase-2 leveis in patients with gastric carcinoma. Cancer 91, 1876-1881.
23. Paganini-Hill A., Chao A., Ross R.K. & Henderson B.E. (1989) Aspirin use and chronic diseases: A cohort study of the elderly. B.M.J. 299, 1247-1250.
24. Parrett M.L., Abou-Issa H.M., Alshafie G., Ross M.S., Harris R.E. & Robertson F.M. (1999) Comparative ability of ibuprofen and N-(4-hydroxyphenyl) retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms. Anticancer Res. 19, 5079-5086.
25. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P. & Robertson F.M. (1997) Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol. 10, 503-507.
26. Rao C.V., Rivenson A., Simi B. et al. (1995) Chemoprevention of colon carcinogenesis by sulindac, nonsteroidal anti-inflammatory agent. Cancer Res. 55, 1464-1472.
27. Reddy B.S., Rao C.V., Rivenson A. & Kelloff G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14, 1493-1497.
28. Reddy S.T., Tiano H.F., Langenbach R., Morham S.G. & Herschman H.R. (1999) Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem. Biophys. Res. Comm. 265, 205-210.
29. Robertson F.M., Parrett M.L., Joarder F.S. et al. (1998) Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinoma. Cancer Lett. 122, 165-175.
30. Rosenberg L. (1995) Nonsteroidal anti-inflammatory drugs and cancer. Prev. Med. 24, 107-109.
31. Russo J., Gusterson B.A., Rogers A.E., Russo I.H., Wellings S.R. & van Zwleten M.J. (1990) Comparative study of human and rat mammary tumourigenesis. Laboratory Invest. 62, 244-278.
32. Ryu H.S., Chang K.H., Yang H.W., Kim M.S., Kwon H.C. & Oh K.S. (2000) High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol. Oncol. 76, 320-325.
33. Sawaoka H., Tsuji S., Tsujii M. et al. (1999) Cyclooxygenase inhibitors suppress angiogenesis and reduce tumour growth in vivo. Laboratory Invest. 79, 1469-1477.
34. Schreinemachers D.M. & Everson R.B. (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5, 138-146.
35. Seibert K., Zhang Y., Leahy K. et al. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Nat. Acad. Sci. USA 91, 12013-12017.
36. Sgambato A., Han E.K.H., Zhang Y.J., Moon R.C., Santella R.H. & Weinstein I.B. (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumours. Carcinogenesis 16, 2193-2198.
37. Shao J., Sheng H., Aramandla R. et al. (1999) Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumours. Carcinogenesis 20, 185-191.
38. Shattuck-Brandt R.L., Lamps L.W., Heppner Goss K.J., Dubois R.N. & Matrisian L.M. (1999) Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol. Carcinog. 24, 177-187.
39. Sonoshita M., Takaku K., Sasaki N. et al. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice. Nat. Med. 7, 1048-1051.
40. Soslow R.A., Dannenberg A.J., Rush D. et al. (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumours. Cancer 89, 2637-2645.
41. Sousa A., Pfister R., Christie P.E. et al. (1997) Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 52, 940-945.
42. Thun M.J., Namboodiri M.M., Calle E.E., Flanders W.D. & Heath C.W. Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res. 53, 1322-1327.
43. Thun M.J., Namboodiri M.M. & Heath C.W. Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N. Eng. J. Med. 325, 1593-1596.
44. Tjandrawinata R.R. & Hughes-Fulford M. (1997) Up-regulation of cyclooxygenase-2 by product-prostaglandin E2. Adv. Exp. Med. Biol. 407, 163-170.
45. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M. & Dubois R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716.
46. Van J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 231, 232-235.
47. Vane J. (1994) Towards a better aspirin. Nature 367, 215-216.
48. Westphal E. (1891) Über mastzellen. In: Farbenanalytische Untersuchungen. Zur Histologie und Klinik des Blutes: Gesammelte Mitt(h)eilungen, Vol. 1. (Ed. P. Ehrlich). Berlin: Hirschwald Press, p. 17.